Observations placeholder
Prolia, Denosumab and Xgeva
Identifier
024133
Type of Spiritual Experience
Number of hallucinations: 39
Background
A description of the experience
Denosumab (trade names Prolia and Xgeva) is a human monoclonal antibody for the treatment of osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone.
The most common side effects are joint and muscle pain in the arms or legs. Denosumab is contraindicated in people with low blood calcium levels. Denosumab is a RANKL inhibitor, which works by preventing the development of osteoclasts which are cells that break down bone. It was developed by the biotechnology company Amgen.
Most common Prolia side effects from eHealthme
- Death - (5,610 reports)
- Back pain - (2,320 reports)
- Joint pain - (2,319 reports)
- Pain in extremity - (2,308 reports)
- Rashes - (1,944 reports)
- Pain - (1,897 reports)
- Osteonecrosis of jaw - (1,373 reports)
- Muscle aches - (1,260 reports)
- Weakness - (1,225 reports)
- Bone pain - (1,092 reports)
Most common Xgeva side effects from eHealthme
- Death - (2,102 reports)
- Osteonecrosis of jaw - (1,767 reports)
- Hypocalcaemia - (762 reports)
- Fatigue - (637 reports)
- Hospitalisation - (499 reports)
- Nausea - (396 reports)
- Weakness - (361 reports)
- Breathing difficulty - (357 reports)
- Diarrhea - (349 reports)
- Pain - (336 reports)
On Jan, 28, 2017 34,310 people reported to have side effects when taking Prolia. Among them, 26 people (0.08%) have Hallucination
On Feb, 14, 2017 34,310 people reported to have side effects when taking Prolia. Among them, 7 people (0.02%) have Hallucination, Auditory
On Jan, 24, 2017 11,014 people reported to have side effects when taking Xgeva. Among them, 6 people (0.05%) have Hallucination